About CG Oncology (CGON)
CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The Company’s product candidate, cretostimogen... Read more
- USD28.57
- USD30.23
- USD28.36
- USD40.47
- 30.60%
- 1M
- 1.16M
- 1.83M
- 1.7B
- 14.80
- -26.50%
Stock News
3 hours ago
How Capital One can get an even bigger payoff from its Discover purchase
CNBC
4 hours ago
Here’s what I’ve learned after writing about Apple, Intel and Silicon Valley for over 30 years
MarketWatch
5 hours ago
Bank of the James Financial Group First Quarter 2025 Earnings: EPS: US$0.18 (vs US$0.48 in 1Q 2024)
Yahoo
5 hours ago
Brain health experts' top 3 tips for lowering your risk of dementia, stroke and depression—all at the same time
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
